This brand name is authorized in United States. It is also authorized in Australia, Austria, Canada, Estonia, France, Hong Kong SAR China, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, Spain, Turkey, UK.
The drug ZYKADIA contains one active pharmaceutical ingredient (API):
1
|
UNII
K418KG2GET - CERITINIB
|
|
Ceritinib is an orally highly selective and potent ALK inhibitor. Ceritinib inhibits autophosphorylation of ALK, ALK-mediated phosphorylation of downstream signalling proteins and proliferation of ALK-dependent cancer cells both in vitro and in vivo. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| ZYKADIA Hard capsule | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| L01ED02 | L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01E Protein kinase inhibitors → L01ED Anaplastic lymphoma kinase (ALK) inhibitors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 11056X |
| CA | Health Products and Food Branch | 02436779 |
| EE | Ravimiamet | 1684560, 1697115, 1766088, 1792559 |
| ES | Centro de información online de medicamentos de la AEMPS | 115999001 |
| FR | Base de données publique des médicaments | 66958808 |
| GB | Medicines & Healthcare Products Regulatory Agency | 379924 |
| HK | Department of Health Drug Office | 64236 |
| IE | Health Products Regulatory Authority | 88742 |
| JP | 医薬品医療機器総合機構 | 4291044F1022 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1076640, 1078234, 1084938, 1087492 |
| NL | Z-Index G-Standaard, PRK | 125938, 199608 |
| PL | Rejestru Produktów Leczniczych | 100342909, 100433606 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W64628001, W64628002 |
| SG | Health Sciences Authority | 14776P |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699504152050 |
| US | FDA, National Drug Code | 0078-0694 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.